Alan - Advanced Biomed Director Relations
| ADVB Stock | 0.30 0.01 3.45% |
Director
Alan is Director Relations of Advanced Biomed Common
| Web | https://www.advanbiomed.com |
Advanced Biomed Management Efficiency
The company has return on total asset (ROA) of (0.3528) % which means that it has lost $0.3528 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6498) %, meaning that it created substantial loss on money invested by shareholders. Advanced Biomed's management efficiency ratios could be used to measure how well Advanced Biomed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | DIRECTOR Age | ||
| Elizabeth Donnelly | Marker Therapeutics | N/A | |
| MariaBernadette Madel | Marker Therapeutics | 36 | |
| Robert Goodman | Beyond Air | 61 | |
| James Walsh | Trinity Biotech plc | 68 | |
| Jacqueline ONeill | Trinity Biotech plc | 53 | |
| Steve Liu | Ridgetech | N/A | |
| Ronan ACA | Trinity Biotech plc | 70 | |
Management Performance
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.35 |
Advanced Biomed Common Leadership Team
Elected by the shareholders, the Advanced Biomed's board of directors comprises two types of representatives: Advanced Biomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Advanced. The board's role is to monitor Advanced Biomed's management team and ensure that shareholders' interests are well served. Advanced Biomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Advanced Biomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mingze Yin, Chief Officer | ||
| Hung Pau, Secretary Director | ||
| Alan, Director Relations | ||
| Yi Lu, CEO Chairman | ||
| IFang Cheng, Chief Officer |
Advanced Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Advanced Biomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 3.69 M | ||||
| Shares Outstanding | 21.64 M | ||||
| Shares Owned By Insiders | 77.53 % | ||||
| Shares Owned By Institutions | 1.22 % | ||||
| Number Of Shares Shorted | 662.89 K | ||||
| Price To Book | 2.10 X | ||||
| EBITDA | (90.81 K) | ||||
| Net Income | (101.52 K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Biomed Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.